Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 5/20 | 0.38 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | KIF11 | P52732 | 2/20 | 0.34 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20111605 | 0.95 | ALOX5AP (0.36) | ARPGRKIF11ALOX5APFEN1 | |
| SCHEMBL25658682 | 0.95 | AR (0.38) | ARPGRKIF11ALOX5APFEN1 | |
| SCHEMBL25659515 | 0.95 | AR (0.38) | ARPGRKIF11ALOX5APFEN1 | |
| SCHEMBL21258680 | 0.95 | AR (0.42) | ARPGRKIF11ALOX5APFEN1 | |
| SCHEMBL21258880 | 0.93 | KIF11 (0.40) | ARPGRKIF11PTGER4DGAT1 | |
| SCHEMBL20111849 | 0.93 | KIF11 (0.36) | ARKIF11ELANETRPA1RORC | |
| SCHEMBL25658583 | 0.93 | KIF11 (0.36) | ARKIF11ELANETRPA1RORC | |
| SCHEMBL21546644 | 0.93 | AR (0.37) | ARPGRALOX5APFEN1EDNRB | |
| SCHEMBL21258719 | 0.92 | ALOX5AP (0.36) | ARPGRKIF11ALOX5APFEN1 | |
| SCHEMBL20111885 | 0.92 | PTPN5 (0.39) | ARPGRKIF11TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| EP-3585777-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2023-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | AR 4630/4885PGR 3250/4885KIF11 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.